PHONE 212.358.5762
  
  244 Fifth Avenue Suite 2369 New York NY 10001
 
 
 
 
 
 

. . . . .
. .
. .
. .
. . . . .
 
AMBIEN CASE INDEX - updated 6-1-07
- SCL in the Media Explains the Ambien Class Action, Effects of Ambien, Expert Reviews & Sanofi's Responses

CASE UPDATES: 

The Class Action was withdrawn May 17, 2007 as discussed below
-FDA DIRECTS STRONGER WARNINGS FOR AMBIEN 3-14-07

-AMBIEN MANUFACTURER TO CONTACT CONSUMERS
- 3-14-07 Letter of Sanofi to SCL
- 3-08-07 SCL Letter to Sanofi

- Scheduling Order signed 6/4/06  

- Amended Class Action Complaint filed 4/24/06

- Class Action Complaint filed 3/6/06


Case Closed:

After over a year of investigation and reviewing about 1,000 forms and other data from people nationwide, it was determined that there were too many different factual differences between potential claimants that would prevent a class from being certified by the court.  The law requires  common injuries and damages between everyone.  In this case, everyone had a difference, whether it was their being on other medications or how they took Ambien; it was different enough to determine a class action was not best.  Our offices always maintained from the start of this action that our goal was twofold: (1) to make people aware that they could suffer adverse reactions from Ambien that they did not know about and (2)to get stronger warnings about this drug.  We accomplished that when we put this issue out to the media and on March 14, 2007 the FDA directed the Ambien manufacturer  to provide the very warnings this lawsuit demanded.   No other office nationwide would at least take that responsibility.  We did, and we got a result, and we did not receive any compensation other than accomplishing what we promised.

 YOU CAN HIRE YOUR OWN COUNSEL AND COMMENCE AN INDIVIDUAL ACTION AGAINST THE MANUFACTURER IF YOU BELIEVE YOU HAVE A CASE.